Cargando…
Repeated intravenous thrombolysis in early recurrent stroke secondary to carotid web: Case report
Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the first effective approved treatment for reducing ischemic stroke disability, and having a stroke within 3 months is usually a contraindication to thrombolysis. In this paper, we describe the case of a 58-year-old pa...
Autores principales: | Bouchal, Siham, Lamrani, Youssef Alaoui, Chtaou, Naima, Maaroufi, Mustafa, Belahsen, Faouzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847828/ https://www.ncbi.nlm.nih.gov/pubmed/33552336 http://dx.doi.org/10.1016/j.radcr.2021.01.026 |
Ejemplares similares
-
Reasons for Exclusion From Intravenous Thrombolysis in Acute Ischemic Stroke: Experience From a Moroccan Stroke Unit
por: Siham, Bouchal, et al.
Publicado: (2023) -
L’encéphalopathie de Gayet Wernicke: aspects cliniques et anomalies radiologiques
por: Bouchal, Siham, et al.
Publicado: (2020) -
Recurrent stroke in young adults caused by atypical fibromuscular carotid dysplasia()
por: Charifi, Yahya, et al.
Publicado: (2022) -
Pulmonary and intracranial miliary tuberculosis secondary to Behçet's anti-TNF alfa treatment
por: Sekkat, Asmae, et al.
Publicado: (2020) -
Intravenous thrombolysis with rt-PA in stroke: experience of the moroccan stroke unit
por: Chtaou, Naima, et al.
Publicado: (2016)